Deficient Emotional Self-Regulation (DESR) Completed Phase 2 Trials for Lisdexamfetamine (DB01255)

Also known as: Deficient Emotional Self-Regulation

Indication	Status	Phase
DBCOND0053321 (Deficient Emotional Self-Regulation (DESR))	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01399827	Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits	Treatment	Amphetamine (DB00182) Atomoxetine (DB00289) Dexmethylphenidate (DB06701) Dextroamphetamine (DB01576) Lisdexamfetamine (DB01255) Methylphenidate (DB00422) Omega-3 fatty acids (DB11133)